m m m m m m m
ntal Hygienist 9th Edition
m m m
by Elena Bablenis Haveles, Chapters 1 - 26 A+
m m m m m m m m
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writi
m m m m m m m m m m
ng
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
m m m m m m m m
MULTIPLEmCHOICE
1. Knowledgemofmpharmacologymaidsmthemdentalmprofessionalmin
a. obtainingmampatient’smhealthmhistory.
b. administeringmdrugsminmthemoffice.
c. handlingmemergencymsituations.
d. selectionmofmamnonprescriptionmmedication.
e. Allmofmthemabove.
ANSWER:m E
Allmofmthemchoicesmaremtrue.mBecausemmanymofmourmpatientsmarembeingmtreatedmwithmdrugs,mknowledgem
ofmpharmacologymhelpsminmunderstandingmandminterpretingmpatients’mresponsesmtomhealthmhistorymquesti
ons.mKnowledgemofmthemtherapeuticmandmadversemeffectsmofmmedicationsmobviouslymhelpsminmtheirmprop
ermadministrationminmthemoffice.mEmergencymsituationsmmaymbemcausedmbymdrugsmormtreatedmbymdrugs;mt
hus,mknowledgemofmpharmacologymismofmgreatmhelp,mespeciallymbecausemamrapidmresponsemismsometimes
mrequired.mAmclearmunderstandingmofmthemconceptsmofmdrugmaction,mdrugmhandlingmbymthembody,mandmdr
ugminteractionsmwillmallowmthemdentalmpractitionermtommakempropermjudgmentsmandmgraspmthemconceptsm
relevantmtomnewmdrugmtherapiesmonmthemmarket.
DIF: Application
REF:m RolemofmthemDentalmHygienistm(Medication/HealthmHistory),mRolemofmthemDentalmHygienistm(Medicati
onmAdministration),mRolemofmthemDentalmHygienistm(EmergencymSituations),mRolemofmthemDentalmHygienist
m(NonprescriptionmMedication)m|mpp.m2-3 OBJ: 1
TOP:m NBDHE,m6.0.mPharmacology
2. Whichmofmthemfollowingmstatementsmismtruemregardingmplanningmappointments?
a. Whethermormnotmpatientsmaremtakingmmedicationmformsystemicmdiseasesmismofmlittl
e
consequenceminmthemdentalmoffice.
b. Asthmaticmpatientsmshouldmhavemdentalmappointmentsminmthemmorning.
c. Diabeticmpatientsmusuallymhavemfewermproblemsmwithmammorningmappointment
comparedmwithmafternoonmappointments.
d. BothmBmandmCmaremtrue.
ANSWER:m D
Asthmaticmpatientsmwhomexperiencemdentalmanxietymshouldmschedulemtheirmappointmentsmwhenmtheymar
emnotmrushedmormundermpressuremearlyminmthemmorning.mDiabeticmpatientsmusuallymhavemrelativelymfewer
mproblemsmwithmammorningmappointment.mPatientsmtakingmmedicationmformsystemicmdiseasesmmaymrequir
emspecialmhandlingminmthemdentalmoffice.
, DIF: Comprehension
REF:m RolemofmthemDentalmHygienistm(AppointmentmScheduling)m|mp.
m3m
OBJ:m 1 TOP:m NBDHE,m6.0.mPharmacology
3. Nutritionalmormherbalmsupplements
a. carrymthemU.S.mFoodmandmDrugmAdministrationm(FDA)mapprovalmformdiseasemstates.
b. aremnotmdrugs.
c. canmcausemadversemeffects.
d. willmnotminteractmwithmothermdrugsmthempatientmmaymbemtaking.
ANSWER:m C
Nutritionalmormherbalmsupplementsmaremquitemcapablemofmcausingmadversemeffects.mThemmajority
mofm
nutritionalmormherbalmsupplementsmdomnotmcarrymFDAmapprovalmformtreatingmdiseasemstates.m
Thesemsupplementsmaremdrugsmandmcanmcausemadversemeffectsmandminteractmwithmdifferentmdrugs
.
DIF:m Comprehension
REF:mRolemofmthemDentalmHygienistm(NutritionalmormHerbalmSupplements)m|mp
.m3mOBJ:m 1 TOP:m NBDHE,m6.0.mPharmacology
4. Whichmtypemofmdrugmnamemusuallymbeginsmwithmamlowercasem letter?
a. Brandmname
b. Codemname
c. Genericmname
d. Trademname
ANSWER:m C
Beforemanymdrugmismmarketed,mitmismgivenmamgenericmnamemthatmbecomesmthem“official”mnamemofmthemdru
g.mEachmdrugmismassignedmonlymonemgenericmnamemselectedmbymthemU.S.mAdoptedmNamemCouncil,mandmt
hemnamemismnotmcapitalized.mThembrandmnamemismequivalentmtomthemtrademnamemandmismcapitalized.mAlth
oughmthembrandmnamemismtechnicallymthemnamemofmthemcompanymmarketingmthemproduct,mthismtermmismoft
enmusedminterchangeablymwithmthemtrademname.mThemcodemnamemismtheminitialmtermmusedmwithinmamphar
maceuticalmcompanymtomrefermtomamdrugmwhilemitmismundergoingminvestigationmandmismoftenmamcombinati
onmofmcapitalmlettersmandmnumbers,mthemlettersmrepresentingmanmabbreviationmofmthemcompanymname.
DIF: Comprehension
REF:mDrugmNamesm|mp.m4mOBJ:m 3
TOP:m NBDHE,m6.0.mPharmacology
5. Amdrug’smgenericmnamemismselectedmbymthe
a. pharmaceuticalmcompanymmanufacturingmit.
b. FoodmandmDrugmAdministrationm(FDA).
c. U.S.mAdoptedmNamemCouncil.
d. FederalmPatentmOffice.
, ANSWER:m C
Eachmdrugmismassignedmonlymonemgenericmnamem(e.g.,mibuprofen).mItmismselectedmbymthemU.S.mAdoptedm
NamemCouncil.mThemgenericmnamemismnotmselectedmbymthemFDAmormthemFederalmPatentmOffice.mThemph
armaceuticalmcompanymmanufacturingmthemdrugmclearlymhasmanminfluencemonmthemgenericmnamemgivenmit
smdrug,mbutmthemfinalmdecisionmismnotmthemcompany’s.
DIF: Recall REF:m DrugmNamesm|mp.m4
OBJ:m 3mTOP:m NBDHE,m6.0.mPharmacology
6. Whichmofmthemfollowingmismtruemconcerningmgenericmandmtrademnamesmofmdrugs?
a. Amdrugmmaymonlymhavemonemgenericmnamemandmonemtrademname.
b. Amdrugmmaymonlymhavemonemgenericmname,mbutm itmmaymhavemseveralmtrademnames
.
c. Amdrugmmaymhavemseveralmgenericmnames,mbutmitmmaymonlymhavemonemtrademname
.
d. Amdrugmmaymhavemseveralmgenericmnamesmandmseveralmtrademnames.
ANSWER:m B
Eachmdrugmhasmonlymonemgenericmnamembutmmaymhavemseveralmtrademnames.mFormeachmdrug,mtheremismon
lymonemgenericmname.mItmismnotmcapitalized,mandmitmbecomesmthem“official”mnamemofmthemdrug.mThemphar
maceuticalmcompanymdiscoveringmthemdrugmgivesmthemdrugmamtrademname.mThemtrademnamemismprotectedm
bymthemFederalmPatentmLawmform20myearsmfrommthemearliestmclaimedmfilingmdate,mplusmpatentmtermmextensi
ons.mAlthoughmthembrandmnamemismtechnicallymthemnamemofmthemcompanymmarketingmthemproduct,mitmismof
tenmusedminterchangeablymwithmthemtrademname.
DIF: Comprehension
REF:mDrugmNamesm|mp.m4mOBJ:m 3
TOP:m NBDHE,m6.0.mPharmacology
7. Twomdrugsmthatmaremfoundmtombemchemicallymequivalent,mbutmnotmbiologicallymequivalent
mormtherapeuticallymequivalentmaremsaidmtomdiffermin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticmindex.
ANSWER:m C
Ampreparationmcanmbemchemicallymequivalentmyetmnotmbiologicallymormtherapeuticallymequivalent.mThes
emproductsmaremsaidmtomdifferminmtheirmbioavailability.mThempotencymofmamdrugmismamfunctionmofmthemamou
ntmofmdrugmrequiredmtomproducemanmeffect.mThemefficacymismthemmaximummintensitymofmeffectmormrespon
semthatmcanmbemproducedmbymamdrug.mThemtherapeuticmindexmismthemratiomofmthemlethalmdosemform50%mofm
themexperimentalmanimalsmdividedmbymthemeffectivemdosemform50%mofmthemexperimentalmanimals.mIfmthe
mvaluemofmthemtherapeuticmindexmismsmall,mtoxicitymismmoremlikely.
DIF: Recall
REF:m DrugmNamesm(DrugmSubstitution)m|mp.m5mOBJ:m 4
TOP:m NBDHE,m6.0.mPharmacology